Progress of perioperative chemotherapy of locally advanced gastric cancer
10.3760/cma.j.issn115396-20200708-00224
- VernacularTitle:局部进展期胃癌围手术期化疗的研究进展
- Author:
Xuewei DING
1
;
Han LIANG
Author Information
1. 天津医科大学肿瘤医院胃部肿瘤科，国家肿瘤临床医学研究中心，天津市肿瘤防治重点实验室，天津市恶性肿瘤临床医学研究中心 300060
- From:
International Journal of Surgery
2020;47(11):730-735
- CountryChina
- Language:Chinese
-
Abstract:
Gastrectomy with D2 lymph node dissection has become the global standard procedure for locally advanced gastric cancer. Based on the evidence of the clinic trials, postadjuvant chemotherapy after D2 gastrectomy is the current standard strategy. Neoadjuvant chemotherapy can increase the R0 resection rate, but the consensus has not been reached. These trials could lead to new evidence for improved treatment of gastric cancer in the near future. This review will summarize recent evidence on the benefits of for locally advanced gastric cancer.
